Skip to search formSkip to main contentSkip to account menu

TG100801

Known as: TG 100801, TG-100801 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Development of novel benzotriazines for drug discovery
Background: The synthesis of novel benzotriazine heterocycles was developed independently around the same time by Bischler… 
2008
2008
Eye diseases: Convenient leakage reduction
available therapies for eye diseases associated with abnormal retinal vascular permeability, such as age-related macular… 
2007
2007
Ocular and systemic distribution, and excretion of radioactivity following topical ocular administration of 14C‐TG100801 to pigmented rabbits
Purpose: To determine the ocular distribution, systemic exposure, and routes of excretion of single 0.44 mg/eye topical ocular… 
2006
2006
Topical Administration of Tg100801, a Multi–Targeted Tyrosine Kinase Prodrug, Inhibits Choroidal Neovascularization in Mice
2006
2006
Ocular Drug Distribution of TG100801 (VEGFR2 Inhibitor) and TG100572 (VEGFR2, PDGFR, Src Inhibitor) Following Topical Instillation in Multiple Preclinical Species
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)